98 related articles for article (PubMed ID: 24630396)
1. Altered expression and localization of desmoglein 3 in esophageal squamous cell carcinoma.
Fang WK; Chen B; Xu XE; Liao LD; Wu ZY; Wu JY; Shen J; Xu LY; Li EM
Acta Histochem; 2014 Jun; 116(5):803-9. PubMed ID: 24630396
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of desmoglein 2 and desmoglein 3 in esophageal squamous cell carcinoma.
Fang WK; Gu W; Liao LD; Chen B; Wu ZY; Wu JY; Shen J; Xu LY; Li EM
Asian Pac J Cancer Prev; 2014; 15(2):871-6. PubMed ID: 24568510
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of desmocollin 3, desmoglein 3, and beta-catenin in oral squamous cell carcinoma: correlation with lymph node metastasis and cell proliferation.
Wang L; Liu T; Wang Y; Cao L; Nishioka M; Aguirre RL; Ishikawa A; Geng L; Okada N
Virchows Arch; 2007 Nov; 451(5):959-66. PubMed ID: 17846785
[TBL] [Abstract][Full Text] [Related]
4. The role of desmoglein-3 in the diagnosis of squamous cell carcinoma of the lung.
Savci-Heijink CD; Kosari F; Aubry MC; Caron BL; Sun Z; Yang P; Vasmatzis G
Am J Pathol; 2009 May; 174(5):1629-37. PubMed ID: 19342368
[TBL] [Abstract][Full Text] [Related]
5. DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis.
Chen YJ; Chang JT; Lee L; Wang HM; Liao CT; Chiu CC; Chen PJ; Cheng AJ
Oncogene; 2007 Jan; 26(3):467-76. PubMed ID: 16878157
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
7. Reduced membranous and ectopic cytoplasmic expression of DSC2 in esophageal squamous cell carcinoma: an independent prognostic factor.
Fang WK; Gu W; Li EM; Wu ZY; Shen ZY; Shen JH; Wu JY; Pan F; Lv Z; Xu XE; Huang Q; Xu LY
Hum Pathol; 2010 Oct; 41(10):1456-65. PubMed ID: 20621329
[TBL] [Abstract][Full Text] [Related]
8. Correlation between secreted protein acidic and rich in cysteine protein expression and the prognosis of postoperative patients exhibiting esophageal squamous cell carcinoma.
Wu J; Zhang JR; Jiang XQ; Cao XG
Mol Med Rep; 2017 Sep; 16(3):3401-3406. PubMed ID: 28713937
[TBL] [Abstract][Full Text] [Related]
9. Expression of Cofilin-1 and Transgelin in Esophageal Squamous Cell Carcinoma.
Zhang Y; Liao R; Li H; Liu L; Chen X; Chen H
Med Sci Monit; 2015 Sep; 21():2659-65. PubMed ID: 26344167
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma.
Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y
Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817
[TBL] [Abstract][Full Text] [Related]
11. A potential link between desmoglein 3 and epidermal growth factor receptor in oral squamous cell carcinoma and its effect on cetuximab treatment efficacy.
Minabe M; Akiyama Y; Higa K; Tachikawa T; Takahashi S; Nomura T; Kouno M
Exp Dermatol; 2019 May; 28(5):614-617. PubMed ID: 30907457
[TBL] [Abstract][Full Text] [Related]
12. Expression of kallikrein-related peptidase 13 is associated with poor prognosis in esophageal squamous cell carcinoma.
Nohara K; Yamada K; Yamada L; Hagiwara T; Igari T; Yokoi C; Soma D; Yamashita S; Dohi T; Kawamura YI
Gen Thorac Cardiovasc Surg; 2018 Jun; 66(6):351-357. PubMed ID: 29582368
[TBL] [Abstract][Full Text] [Related]
13. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
[TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
Zhang Y; Liu YP; Du K; Wang H; Wang XL
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
[TBL] [Abstract][Full Text] [Related]
15. A molecular study of desmosomes identifies a desmoglein isoform switch in head and neck squamous cell carcinoma.
Teh MT; Parkinson EK; Thurlow JK; Liu F; Fortune F; Wan H
J Oral Pathol Med; 2011 Jan; 40(1):67-76. PubMed ID: 20923451
[TBL] [Abstract][Full Text] [Related]
16. PI3K Overexpression and PIK3CA Mutations Are Associated with Age, Tumor Staging, and Other Clinical Characteristics in Chinese Patients with Esophageal Squamous Cell Carcinoma.
Lin JW; Li X; Qiu ML; Luo RG; Lin JB; Liu B
Genet Test Mol Biomarkers; 2017 Apr; 21(4):236-241. PubMed ID: 28384037
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of matrix metalloproteinase 10 is associated with poor survival in patients with early stage of esophageal squamous cell carcinoma.
Liu H; Qin YR; Bi J; Guo A; Fu L; Guan XY
Dis Esophagus; 2012; 25(7):656-63. PubMed ID: 22121946
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
19. Desmoglein-3/γ-catenin and E-cadherin/ß-catenin differential expression in oral leukoplakia and squamous cell carcinoma.
Kyrodimou M; Andreadis D; Drougou A; Amanatiadou EP; Angelis L; Barbatis C; Epivatianos A; Vizirianakis IS
Clin Oral Investig; 2014 Jan; 18(1):199-210. PubMed ID: 23430339
[TBL] [Abstract][Full Text] [Related]
20. Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumors.
Viehweger F; Azem A; Gorbokon N; Uhlig R; Lennartz M; Dwertmann Rico S; Kind S; Reiswich V; Kluth M; Hube-Magg C; Bernreuther C; Büscheck F; Clauditz TS; Fraune C; Jacobsen F; Krech T; Lebok P; Steurer S; Burandt E; Minner S; Marx AH; Simon R; Sauter G; Menz A; Hinsch A
Pathol Res Pract; 2022 Dec; 240():154200. PubMed ID: 36375372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
